ALEXANDRA HEMBREE: Open Payments
NPI 1881210656 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 32 payments from 13 companies in 2025. Trend: 2023 $397 · 2024 $241 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $250 |
| Genentech USA, Inc. | 2 | $125 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $94 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 2 | $39 |
| Ionis Pharmaceuticals, Inc. | 1 | $33 |
| Grifols USA, LLC | 1 | $22 |
| BioCryst US Sales Co., LLC | 1 | $20 |
Products named: Xolair, AIRSUPRA, DUPIXENT, FASENRA, NEFFY, ZORYVE, DAWNZERA, Rhapsido.
Industry payments across TX — which companies pay providers there.
